Literature DB >> 23343597

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.

Marcos Hortes N Chagas1, José Alexandre S Crippa, Antonio Waldo Zuardi, Jaime E C Hallak, João Paulo Machado-de-Sousa, Camila Hirotsu, Lucas Maia, Sergio Tufik, Monica Levy Andersen.   

Abstract

UNLABELLED: Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle.
OBJECTIVE: The objective of this paper is to assess the effects on sleep of acute systemic administration of CBD.
METHOD: Adult male Wistar rats were randomly distributed into four groups that received intraperitoneal injections of CBD 2.5 mg/kg, CBD 10 mg/kg, CBD 40 mg/kg or vehicle (n=seven animals/group). Sleep recordings were made during light and dark periods for four days: two days of baseline recording, one day of drug administration (test), and one day after drug (post-test).
RESULTS: During the light period of the test day, the total percentage of sleep significantly increased in the groups treated with 10 and 40 mg/kg of CBD compared to placebo. REM sleep latency increased in the group injected with CBD 40 mg/kg and was significantly decreased with the dose of 10 mg/kg on the post-test day. There was an increase in the time of SWS in the group treated with CBD 40 mg/kg, although this result did not reach statistical significance.
CONCLUSION: The systemic acute administration of CBD appears to increase total sleep time, in addition to increasing sleep latency in the light period of the day of administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343597     DOI: 10.1177/0269881112474524

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  20 in total

Review 1.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Authors:  Kimberly A Babson; James Sottile; Danielle Morabito
Journal:  Curr Psychiatry Rep       Date:  2017-04       Impact factor: 5.285

2.  Natural Cannabinoids as Templates for Sleep Disturbances Treatments.

Authors:  Eric Murillo-Rodríguez; Sérgio Machado; Claudio Imperatori; Tetsuya Yamamoto; Henning Budde
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Addiction and Sleep Disorders.

Authors:  Jonathan Ek; William Jacobs; Brett Kaylor; W Vaughn McCall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Authors:  José Alexandre S Crippa; Jaime E C Hallak; Antônio W Zuardi; Francisco S Guimarães; Vitor Tumas; Rafael G Dos Santos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-31       Impact factor: 5.270

5.  Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Authors:  Kristin E Maple; Kymberly A McDaniel; Skyler G Shollenbarger; Krista M Lisdahl
Journal:  Am J Drug Alcohol Abuse       Date:  2016-04-13       Impact factor: 3.829

Review 6.  Are Sweet Dreams Made of These? Understanding the Relationship Between Sleep and Cannabis Use.

Authors:  Dalton Edwards; Francesca M Filbey
Journal:  Cannabis Cannabinoid Res       Date:  2021-06-18

Review 7.  Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Authors:  Maureen L Petrunich-Rutherford; Michael W Calik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.

Authors:  Malvika Kaul; Phyllis C Zee; Ashima S Sahni
Journal:  Neurotherapeutics       Date:  2021-02-12       Impact factor: 7.620

9.  Cannabis use as a moderator of cognitive behavioral therapy for insomnia.

Authors:  Mary Beth Miller; Ryan W Carpenter; Lindsey K Freeman; Ashley F Curtis; Ali M Yurasek; Christina S McCrae
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

10.  Potential effects of cannabidiol as a wake-promoting agent.

Authors:  Eric Murillo-Rodríguez; Andrea Sarro-Ramírez; Daniel Sánchez; Stephanie Mijangos-Moreno; Alma Tejeda-Padrón; Alwin Poot-Aké; Khalil Guzmán; Elda Pacheco-Pantoja; Oscar Arias-Carrión
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.